What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Publication Nov 6, 2024
Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Christopher Ma, Vipul Jairath, Virginia Salitano

Article Oct 11, 2023
Ultimate Guide to Contract Research Organization Market Size

Due to Contract Research Organizations’ (CROs) significant impact on drug development and healthcare advancements, understanding the size and future growth of the CRO Market is…

News Oct 10, 2023
Alimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical Trials

London, Canada and Vancouver, Canada – Alimentiv, a global contract research organization (CRO) providing clinical trials, central image management, precision medicine, and real-world evidence services…

Article Oct 2, 2023
How Diversity Impacts Clinical Trials

The lack of diversity in clinical trial populations has been a longstanding issue in the medical and research communities. While some researchers and advocates have…

Article Sep 8, 2023
Different Types of Clinical Trial Designs

Clinical trial designs can be classified into several categories, each with its unique characteristics and objectives. This guide provides a broad look at the many…

Article Aug 2, 2023
Samples, Assays, and Analyses: Building a Biomarker Plan for Precision Medicine in Clinical Trials

Designing a biomarker plan for a clinical trial can be challenging due to the plethora of assays and advancing technologies that are now readily available….

Article Aug 2, 2023
Why aren’t more Clinical Trials using Adaptive Designs?

If adaptive designs can bring strong advantages to clinical trials, then why does their adoption remain low?  Clinical trials typically follow a fixed design, where…